GTG — Genetic Technologies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.4 | 1.96 | 1.75 | 1.84 | 0 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.66 | -9.72 | -9.68 | -1.35 | -0.112 |
| Capital Expenditures | -0.097 | -0.018 | -0.033 | -0.007 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.36 | -0.294 | 0.148 | 0.433 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.46 | -0.312 | 0.115 | 0.426 | 0 |
| Financing Cash Flow Items | -0.01 | -0.916 | -0.007 | -0.037 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.279 | 5.92 | 2.82 | -0.071 | 0.112 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -9.17 | -3.88 | -6.83 | -1.01 | 0 |